ISPOR Chief Science Officer Dr Laura Pizzi Named to NJBIZ's 2026 People to Watch in Healthcare List

Published Jul 29, 2026

Lawrenceville, NJ, USA– July 29, 2026—ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR) is proud to announce its Chief Science Officer, Laura Pizzi, PharmD, MPH, has been recognized by NJBIZ as one of its 2026 People to Watch in Healthcare.

The annual NJBIZ recognition honors healthcare leaders across New Jersey who are driving innovation, advancing patient care, and shaping the future of healthcare through their leadership, expertise, and commitment to improving health outcomes.

As Chief Science Officer at ISPOR, Dr Pizzi leads the Society's scientific strategy and initiatives, advancing the role of health economics and outcomes research (HEOR) in informing healthcare decisions globally. Her work helps foster the development and dissemination of scientific evidence that supports policymakers, healthcare providers, payers, life sciences organizations, and patients in making evidence-informed decisions that improve healthcare value and patient outcomes.

"Laura's passion for scientific excellence and her commitment to advancing the field of HEOR have strengthened ISPOR's role as the leading global professional society dedicated to improving healthcare decision making," said Rob Abbott, CEO of ISPOR. This recognition is a testament to her leadership, vision, and the meaningful impact she continues to make across the healthcare community. We are thrilled to celebrate this well-deserved honor."

"I am deeply honored to be recognized by NJBIZ alongside so many inspiring healthcare leaders," said Dr. Pizzi. "This recognition reflects not only my work but also the dedication of my colleagues at ISPOR and the global HEOR community. Together, we are advancing research and evidence that helps improve healthcare decisions and ultimately create better outcomes for patients around the world."

###

ABOUT ISPOR
ISPOR—The Professional Society for Health Economics and Outcomes Research
(HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.

Website  | LinkedIn  | X (@ispororg)  |  Bluesky  |  YouTube  |  Facebook  |  Instagram  

Related Stories

ISPOR Announces the Healthcare Investment Summit 2026

Jul 20, 2026

ISPOR announced their inaugural Healthcare Investment Summit 2026, which will bring together healthcare investors, founders, pharma and device executives, policy experts, health economists, and access leaders on September 22–23, 2026, in San Francisco to examine the critical factors shaping investment decisions across the healthcare landscape.

New ISPOR Report Introduces "IMPACT" Framework to Guide Value-Based Healthcare Implementation

Jul 13, 2026

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of an ISPOR Special Task Force Report offering good practice recommendations and a new "IMPACT" framework for integrating health economics and outcomes research (HEOR) methods into value-based healthcare implementation.

Promoting Fairness in Funding Decisions

Jun 24, 2026

Value in Health announced the publication of a special themed section of research papers that offer new tools to help health policy makers weigh fairness alongside cost-effectiveness when deciding which treatments and programs to fund.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×